Galenica : Investor Presentation (Version March 2022)
March 08, 2022 at 12:51 am EST
Share
Galenica Group
Investor Presentation
March 2022
Galenica - Health and wellbeing are at the heart of what we do.
About Galenica
Market environment
Business performance
Governance
Sustainability
Outlook
Table of contents
3 About Galenica
Market environment
Business performance
Governance
Sustainability
Outlook
07/03/22
2
About Galenica
Galenica - Health and wellbeing are at the heart of what we do.
3
About Galenica
Market environment
Business performance
Galenica in figures
Net sales
EBIT adjusted1)
in million CHF
in million CHF
Galenica Group
Galenica Group
3,834.7
213.1
Products & Care
Logistics & IT
Products & Care
Logistics & IT
1 Excluding effects of IAS 19 and IFRS 16, see chapter "Alternative performance measures" of the Annual report 2021
07/03/22
4
Governance
Sustainability
Outlook
Leading healthcare
Employees
provider in Switzerland
(Headcount)
368 own pharmacies
> 7,200
Debt coverage adjusted
Equity ratio
1.0x 48.1%
Operating Cash flow adjusted1)
Dividend yield
(in million CHF)
283 million
3.1%
About Galenica
Market environment
Business performance
Governance
Sustainability
Outlook
Building the leading Swiss healthcare platform over 90 years
Foundation of
Joint
Galenica as a
Venture
wholesaler
Strategy to engage in the
entire Swiss Acquisition healthcare
value chain
Organic and acquisition-led expansion of pharmacies network
IPO
Acquisition
Acquisition
Acquisition
Creation of Amavita
Acquisition
uniform brand in
Switzerland
Acquisition
Acquisition
Acquisition
Acquisition
Acquisition
Acquisition
Opening of highly
Acquisition
Relaunch
automated distribution
centre in Niederbipp
1927
1995
2000
2002 / 2004
2005
2007
2008
2009
2013
2017
2018
2019
2020
2021
Corporate
Segment Products & Care
Segment Logistics & IT
07/03/22
5
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Galenica AG published this content on 08 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 March 2022 05:50:08 UTC.
Galenica AG, previously Galenica Sante Ltd, is a Switzerland-based healthcare services and products provider. The Company's business i divided into three business sectors: Retail, Products & Brands, and Services. The Company manages a locally established pharmacies network in Switzerland. It develops and distributes its own product portfolio, as well as cooperates with a range of business partners, such as Pierre Fabre, Ales Groupe and Vitor Consumer Health for marketing and distribution of such brands as Perskindol, Triofan, A-Derma, Lierac, Phyto, Anti-Brumm and Algifor. Galenica Sante's Services business sector is responsible for management of such logistics sector companies as Galexis, Unione Farmaceutica Distribuzione, Alloga and Medifilm.
GALENICA AG 
